J. Goldman & Co’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

J. Goldman & Co’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-394,004	Closed	-$3.95M	–	553
2022 Q3	$3.95M	Hold	394,004	–	–	0.19%	143
2022 Q2	$3.9M	Hold	394,004	–	–	0.19%	130
2022 Q1	$3.88M	Hold	394,004	–	–	0.18%	143
2021 Q4	$3.86M	Buy	394,004 +189,771	+93%	+$1.87M	0.21%	130
2021 Q3	$2M	Hold	204,233	–	–	0.1%	191
2021 Q2	$2.02M	Buy	204,233 +91,601	+81%	+$922K	0.08%	222
2021 Q1	$1.16M	Buy	+112,632	New	+$1.25M	0.04%	293

J. Goldman & Co's LUXA Position: Q4 2022 in Review

J. Goldman & Co sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 394,004 shares — an estimated $3.95M sold.

J. Goldman & Co first reported a position in LUXA in Q1 2021 and held it in 7 quarters. The position peaked at $3.95M in Q3 2022. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

J. Goldman & Co reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
J. Goldman & Co sold 394,004 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022, an estimated $3.95M.
J. Goldman & Co first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q1 2021 and held it in 7 quarters.
J. Goldman & Co's Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $3.95M in Q3 2022.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on J. Goldman & Co's 13F filing for Q4 2022, filed 14 Feb 2023.